Systemic BCNU enhances the efficacy of local delivery of a topoisomerase I inhibitor against malignant glioma

Author： Storm Phillip   Renard Violette   Moriarity John   Tyler Betty   Wilentz Robb   Brem Henry   Weingart Jon  

Publisher： Springer Publishing Company

ISSN： 0344-5704

Source： Cancer Chemotherapy and Pharmacology, Vol.54, Iss.4, 2004-10, pp. : 361-367

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Related content

Efficacy of ribavirin against malignant glioma cell lines

By  

Oncology Letters, Vol. 8, Iss. 6, 2014-01 ,pp. : 2469-2474

Spandidos Publications

Access to resources Recommend Favorite

Local Delivery of Interleukin-2 and Adriamycin is Synergistic in the Treatment of Experimental Malignant Glioma

By Hsu Wesley   Lesniak Maciej   Tyler Betty   Brem Henry  

Journal of Neuro-Oncology, Vol. 74, Iss. 2, 2005-09 ,pp. : 135-140

Springer Publishing Company

Access to resources Recommend Favorite

Vorinostat enhances the cytotoxic effects of the topoisomerase I inhibitor SN38 in glioblastoma cell lines

By Sarcar Bhaswati   Kahali Soumen   Chinnaiyan Prakash  

Journal of Neuro-Oncology, Vol. 99, Iss. 2, 2010-09 ,pp. : 201-207

Springer Publishing Company

Access to resources Recommend Favorite

The cytotoxic effect of β-elemene against malignant glioma is enhanced by base-excision repair inhibitor methoxyamine

By Zhu Yongjian  

Journal of Neuro-Oncology, Vol. 113, Iss. 3, 2013-07 ,pp. : 375-384

Springer Publishing Company

Access to resources Recommend Favorite

Use of Gliadel (BCNU) Wafer in the Surgical Treatment of Malignant Glioma: A 10-Year Institutional Experience

By Attenello Frank  

Annals of Surgical Oncology, Vol. 15, Iss. 10, 2008-10 ,pp. : 2887-2893

Springer Publishing Company

Access to resources Recommend Favorite